Press release
Targeted Drugs for Allergic Diseases Market Size, Share, Trends, and Analysis: 2024-2030
Anaphylaxis is an inappropriate reaction of the immune system to normal harmless substances. It generally has a rapid onset, strong reaction, and rapid subsidence. It has obvious genetic tendencies and individual differences. Currently, the prevalence of allergic diseases is increasing rapidly worldwide, affecting approximately 25% of the global population.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/2392780/targeted-drugs-for-allergic-diseases
According to the new market research report "Targeted Drugs for Allergic Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030", published by QYResearch, the global Targeted Drugs for Allergic Diseases market size is projected to reach USD 91.07 billion by 2030, at a CAGR of 15.7% during the forecast period.
According to QYResearch Top Players Research Center, the global key manufacturers of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, etc. In 2023, the global top five players had a share approximately 75.0% in terms of revenue.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The Targeted Drugs for Allergic Diseases market is segmented as below:
By Company
Sanofi
Novartis
GSK
Amgen
AstraZeneca
Biosion
Pfizer
UCB
Otsuka Pharmaceutical
Roche
Keymed Biosciences
Mabpharm
Genrix Bio
Dragon Boat Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Sunshine Guojian
Qyuns Therapeutics
Segment by Type
IL-4R
TSLP
IL-5
JAK
IgE
IL-33
Others
Segment by Application
Atopic Dermatitis
Asthma
Chronic Sinusitis with Nasal Polyps
Chronic Obstructive Pulmonary Disease
Others
Each chapter of the report provides detailed information for readers to further understand the Targeted Drugs for Allergic Diseases market:
Chapter 1: Introduces the report scope of the Targeted Drugs for Allergic Diseases report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2019-2030)
Chapter 2: Detailed analysis of Targeted Drugs for Allergic Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2019-2024)
Chapter 3: Provides the analysis of various Targeted Drugs for Allergic Diseases market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2019-2030)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2019-2030)
Chapter 5: Sales, revenue of Targeted Drugs for Allergic Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2019-2030)
Chapter 6: Sales, revenue of Targeted Drugs for Allergic Diseases in country level. It provides sigmate data by Type, and by Application for each country/region.(2019-2030)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2019-2024)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth Targeted Drugs for Allergic Diseases competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides Targeted Drugs for Allergic Diseases comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides Targeted Drugs for Allergic Diseases market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global Targeted Drugs for Allergic Diseases Market Insights, Forecast to 2030
Global Targeted Drugs for Allergic Diseases Market Research Report 2024
Global and India Targeted Drugs for Allergic Diseases Market Report & Forecast 2024-2030
Small Molecule Targeted Drugs for Allergic Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Small Molecule Targeted Drugs for Allergic Diseases Market Insights, Forecast to 2030
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
Global and United States Small Molecule Targeted Drugs for Allergic Diseases Market Report & Forecast 2024-2030
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 17 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted Drugs for Allergic Diseases Market Size, Share, Trends, and Analysis: 2024-2030 here
News-ID: 3689618 • Views: …
More Releases from QY Research Inc.
Low CTE Glass Fabrics Market Report 2025-2031: Size, Analysis & Outlook | QYRese …
The global market for Low CTE Glass Fabrics was estimated to be worth US$ 351 million in 2024 and is forecast to a readjusted size of US$ 1133 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Global Leading Market Research Publisher QYResearch announces the release of its latest report "Low CTE Glass Fabrics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based…
Semiconductor Process & Device Simulation Software (TCAD) Market Report 2025-203 …
The global market for Semiconductor Process & Device Simulation Software (TCAD) was estimated to be worth US$ 310 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.
Global Leading Market Research Publisher QYResearch announces the release of its latest report "Semiconductor Process & Device Simulation Software (TCAD) - Global Market Share and Ranking, Overall…
High-Precision Positioning Board Market Report 2025-2031: Size, Analysis & Outlo …
The global market for High-Precision Positioning Board was estimated to be worth US$ 1670 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Global Leading Market Research Publisher QYResearch announces the release of its latest report "High-Precision Positioning Board - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current…
Photoresist Stripping Machines Market Report 2025-2031: Size, Analysis & Outlook …
Unlock the Future of the Photoresist Stripping Machines Market: Comprehensive Global Market Report 2025-2031
Global leading market research publisher QYResearch published the release of its latest report, "Photoresist Stripping Machines - Global Market Share, Ranking, Sales, and Demand Forecast 2025-2031". This in-depth report provides a complete analysis of the global Photoresist Stripping Machines market, offering critical insights into market size, share, demand, industry development status, and future forecasts. Whether you're a…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
